1. Home
  2. CLDI vs REE Comparison

CLDI vs REE Comparison

Compare CLDI & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • REE
  • Stock Information
  • Founded
  • CLDI 2014
  • REE 2011
  • Country
  • CLDI United States
  • REE Israel
  • Employees
  • CLDI N/A
  • REE N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • REE Auto Manufacturing
  • Sector
  • CLDI Health Care
  • REE Consumer Discretionary
  • Exchange
  • CLDI Nasdaq
  • REE Nasdaq
  • Market Cap
  • CLDI 20.2M
  • REE 18.5M
  • IPO Year
  • CLDI N/A
  • REE N/A
  • Fundamental
  • Price
  • CLDI $1.76
  • REE $0.72
  • Analyst Decision
  • CLDI
  • REE Strong Buy
  • Analyst Count
  • CLDI 0
  • REE 2
  • Target Price
  • CLDI N/A
  • REE $11.75
  • AVG Volume (30 Days)
  • CLDI 1.1M
  • REE 60.3K
  • Earning Date
  • CLDI 08-08-2025
  • REE 09-25-2025
  • Dividend Yield
  • CLDI N/A
  • REE N/A
  • EPS Growth
  • CLDI N/A
  • REE N/A
  • EPS
  • CLDI N/A
  • REE N/A
  • Revenue
  • CLDI N/A
  • REE $183,000.00
  • Revenue This Year
  • CLDI N/A
  • REE $6,661.20
  • Revenue Next Year
  • CLDI N/A
  • REE $2,240.01
  • P/E Ratio
  • CLDI N/A
  • REE N/A
  • Revenue Growth
  • CLDI N/A
  • REE N/A
  • 52 Week Low
  • CLDI $1.61
  • REE $0.53
  • 52 Week High
  • CLDI $46.68
  • REE $11.72
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 29.56
  • REE 51.12
  • Support Level
  • CLDI $1.61
  • REE $0.66
  • Resistance Level
  • CLDI $6.06
  • REE $0.73
  • Average True Range (ATR)
  • CLDI 0.77
  • REE 0.04
  • MACD
  • CLDI -0.55
  • REE 0.01
  • Stochastic Oscillator
  • CLDI 2.57
  • REE 64.39

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

Share on Social Networks: